Sarepta Therapeutics Income from Continuous Operations 2010-2024 | SRPT
Sarepta Therapeutics income from continuous operations for the twelve months ending September 30, 2024 was $0.122B, a 117.64% decline year-over-year.
- Sarepta Therapeutics annual income from continuous operations for 2023 was $-0.536B, a 23.81% decline from 2022.
- Sarepta Therapeutics annual income from continuous operations for 2022 was $-0.703B, a 67.99% increase from 2021.
- Sarepta Therapeutics annual income from continuous operations for 2021 was $-0.419B, a 24.43% decline from 2020.